Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/17743

TDMS Study 93021-04 Pathology Tables

NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97
Route: SKIN APPLICATION                                                                                           Time: 10:18:14

                                                       13 WEEK SUBCHRONIC




       Facility:  Microbiological Associates

       Chemical CAS #:  538-75-0

       Lock Date:  05/17/95

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                                                                                 10           
  Survivors                                                                                                                         
    Terminal Sacrifice                                10            9           10           10           10                        
    Accidently Killed                                               1                                                               

  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)                                                (10)         (10)         
      Inflammation, Focal                              1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (10)                                                (10)         (10)         
      Bilateral, Capsule, Hyperplasia                  5 (50%)                                             7 (70%)                  
      Capsule, Hyperplasia                             2 (20%)                                             2 (20%)                  
   Pituitary Gland                                    (9)                                                 (9)          (8)          
      Pars Distalis, Cyst                                                                                               1 (13%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (8)          (7)          (5)          (9)          (7)          (10)         
      Bilateral, Atrophy                                                                                                1 (10%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                                                                             (1)                       
      Inguinal, Hyperplasia                                                                                1 (100%)                 
   Spleen                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Hematopoietic Cell Proliferation                 2 (20%)      2 (20%)      7 (70%)      9 (90%)      5 (50%)      3 (30%)     
   Thymus                                             (10)         (10)         (10)         (9)          (10)         (8)          
      Atrophy                                                                                                           8 (100%)    
      Thymocyte, Necrosis                                                                                               1 (13%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Control, Inflammation                            1 (10%)                                                          1 (10%)     
      Control, Inflammation, Chronic Active            1 (10%)                   3 (30%)      5 (50%)      5 (50%)                  
      Epidermis, Control, Hyperplasia                                                                      3 (30%)                  
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                               5 (50%)      9 (90%)     10 (100%)    10 (100%)     3 (30%)     
      Epidermis, Skin, Site of Application,                                                                                         
          Necrosis                                                                            2 (20%)      3 (30%)     10 (100%)    
      Epidermis, Skin, Site of Application,                                                                                         
          Necrosis, Focal                                                                     1 (10%)                               
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic Active                                           1 (10%)      9 (90%)     10 (100%)    10 (100%)    10 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Pons, Hemorrhage                                                                                                  6 (60%)     
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                                                                                  9           
    Natural Death                                                                                                       1           
  Survivors                                                                                                                         
    Terminal Sacrifice                                 9            9            8           10           10                        
    Accidently Killed                                  1            1            2                                                  

  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)                                                (10)         (10)         
      Inflammation, Focal                                                                                  1 (10%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (10)                                                (10)         (9)          
      Bilateral, Capsule, Hyperplasia                  1 (10%)                                                                      
      Capsule, Hyperplasia                             1 (10%)                                             3 (30%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (9)          (10)         (10)         (10)         (10)         (10)         
      Atrophy                                                                                 1 (10%)                               
      Bilateral, Atrophy                                                                                                4 (40%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Spleen                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Hematopoietic Cell Proliferation                              5 (50%)      2 (20%)      7 (70%)      6 (60%)      6 (60%)     
   Thymus                                             (9)          (10)         (9)          (9)          (10)         (8)          
      Atrophy                                                                                                           8 (100%)    
      Thymocyte, Necrosis                                                                                  1 (10%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Hyperplasia                                                   1 (10%)                                                         
      Control, Inflammation                                                                                1 (10%)                  
      Control, Inflammation, Chronic Active                         1 (10%)      1 (10%)      1 (10%)      3 (30%)                  
      Epidermis, Control, Hyperplasia                                            1 (10%)                                            
      Epidermis, Control, Necrosis                                                                         2 (20%)                  
      Epidermis, Control, Necrosis, Diffuse                                                                1 (10%)                  
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                               7 (70%)     10 (100%)    10 (100%)    10 (100%)                 
      Epidermis, Skin, Site of Application,                                                                                         
          Necrosis                                     1 (10%)                                             2 (20%)     10 (100%)    
      Epidermis, Skin, Site of Application,                                                                                         
          Necrosis, Focal                                                                     2 (20%)                               
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic Active                                           4 (40%)     10 (100%)    10 (100%)    10 (100%)    10 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Pons, Hemorrhage                                                                                                  2 (20%)     
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 93021-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                              DICYCLOHEXYLCARBODIIMIDE                                 Date: 09/02/97  
Route: SKIN APPLICATION                                                                                           Time: 10:18:14  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0            1.5          3            6.0          12           24.0            
                                                   MG/KG        MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------